Patterns and predictors of locoregional recurrence following neoadjuvant chemoradiation for esophageal cancer.

被引:0
|
作者
Blackham, Aaron Udell
Jin, Will
Almhanna, Khaldoun
Fontaine, Jacques-Pierre
Hoffe, Sarah E.
Frakes, Jessica M.
Venkat, Puja
Pimiento, Jose Mario
机构
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ S Florida, Morsani Coll Med, Tampa, FL USA
[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[4] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiat Oncol, Tampa, FL 33682 USA
关键词
D O I
10.1200/jco.2016.34.4_suppl.173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
173
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Preoperative chemoradiation for the treatment of locoregional esophageal cancer: The standard of care?
    Schneider, Bryan J.
    Urba, Susan G.
    SEMINARS IN RADIATION ONCOLOGY, 2007, 17 (01) : 45 - 52
  • [32] Determinants of response to chemoradiation in patients with esophageal cancer.
    Agarwal, B
    Swisher, S
    Kelly, K
    Ajani, J
    Komaki, RU
    Putnam, JB
    Molke, KL
    Lehmann, J
    Bismar, MM
    Walsh, GL
    Correa, AM
    Ho, L
    Liao, ZX
    Lynch, P
    Rice, DC
    Smythe, WR
    Stevens, CW
    Vaporciyan, AA
    Yao, J
    Roth, JA
    GASTROENTEROLOGY, 2002, 122 (04) : A351 - A351
  • [33] TNFerade combined with chemoradiation in resectable esophageal cancer.
    Hanna, N
    Senzer, N
    Reid, T
    Chung, T
    Chang, KJ
    Kessler, P
    Mauer, A
    Posner, M
    Nemuniatis, J
    Swisher, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 243S - 243S
  • [34] Neoadjuvant chemoradiation radiation dose levels for surgically resectable esophageal cancer: predictors of use and outcomes
    Buckstein, M.
    Rhome, R.
    Ru, M.
    Moshier, E.
    DISEASES OF THE ESOPHAGUS, 2018, 31 (05)
  • [35] Can Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer?
    Khaitan, Puja G.
    Holliday, Tyler
    Carroll, Austin
    Hofstetter, Wayne L.
    Bayley, Erin M.
    Zhou, Nicolas
    Desale, Sameer
    Watson, Thomas J.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (07) : 1345 - 1351
  • [36] Can Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer?
    Puja G. Khaitan
    Tyler Holliday
    Austin Carroll
    Wayne L. Hofstetter
    Erin M. Bayley
    Nicolas Zhou
    Sameer Desale
    Thomas J. Watson
    Journal of Gastrointestinal Surgery, 2022, 26 : 1345 - 1351
  • [37] Clinical and Dosimetric Predictors of Perioperative Pulmonary Complications in Esophageal Cancer Patients Treated With Neoadjuvant Chemoradiation
    Shah, J. L.
    Shaffer, J. L.
    Bazan, J. G.
    Cheng, J. C.
    Koong, A. C.
    Chang, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S300 - S301
  • [38] Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation and Surgery for Esophageal Cancer: Does It Improve Outcome?
    Gabriel, E.
    Kim, J.
    Al-Sukhni, E.
    Brady, M.
    Shah, R.
    Attwood, K.
    Hochwald, S.
    Kukar, M.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S177 - S177
  • [39] Complete pathologic response is independent of the timing of esophagectomy following neoadjuvant chemoradiation for esophageal cancer
    Singla, Smit
    Gabriel, Emmanuel
    Alnaji, Raed
    Du, William
    Attwood, Kristopher
    Nava, Hector
    Hochwald, Steven N.
    Kukar, Moshim
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (01) : 73 - 79
  • [40] Patterns of Locoregional Recurrence in Breast Cancer Patients After Neoadjuvant Chemotherapy and Adjuvant Radiation Therapy
    Elebrashi, M.
    Abouegylah, M. L.
    Salama, L. W.
    Mina, A.
    Taghian, A. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E13 - E13